On Friday, MaxCyte Inc (NASDAQ: MXCT) opened higher 4.64% from the last session, before settling in for the closing price of $1.51. Price fluctuations for MXCT have ranged from $1.26 to $5.20 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -11.37%. Company’s average yearly earnings per share was noted 0.43% at the time writing. With a float of $98.23 million, this company’s outstanding shares have now reached $106.64 million.
MaxCyte Inc (MXCT) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of MaxCyte Inc is 7.90%, while institutional ownership is 69.56%. The most recent insider transaction that took place on Jun 25 ’25, was worth 22,378. In this transaction Director of this company sold 10,684 shares at a rate of $2.09, taking the stock ownership to the 39,893 shares. Before that another transaction happened on Aug 13 ’25, when Company’s CHIEF FINANCIAL OFFICER bought 50,000 for $1.29, making the entire transaction worth $64,500. This insider now owns 161,811 shares in total.
MaxCyte Inc (MXCT) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.1 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.12) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.43% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.63% during the next five years compared to -11.37% drop over the previous five years of trading.
MaxCyte Inc (NASDAQ: MXCT) Trading Performance Indicators
Check out the current performance indicators for MaxCyte Inc (MXCT). In the past quarter, the stock posted a quick ratio of 7.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.43, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.26 in one year’s time.
Technical Analysis of MaxCyte Inc (MXCT)
The latest stats from [MaxCyte Inc, MXCT] show that its last 5-days average volume of 0.84 million was superior to 0.77 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 54.85%.
During the past 100 days, MaxCyte Inc’s (MXCT) raw stochastic average was set at 28.83%, which indicates a significant decrease from 61.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1157 in the past 14 days, which was higher than the 0.1051 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5750, while its 200-day Moving Average is $2.3129. Now, the first resistance to watch is $1.6333. This is followed by the second major resistance level at $1.6867. The third major resistance level sits at $1.7633. If the price goes on to break the first support level at $1.5033, it is likely to go to the next support level at $1.4267. The third support level lies at $1.3733 if the price breaches the second support level.
MaxCyte Inc (NASDAQ: MXCT) Key Stats
There are currently 106,607K shares outstanding in the company with a market cap of 168.54 million. Presently, the company’s annual sales total 38,630 K according to its annual income of -41,060 K. Last quarter, the company’s sales amounted to 8,510 K and its income totaled -12,360 K.
